Protagonist Therapeutics, Inc
PTGXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for PTGX. That does not mean none is planned.
Get an email about PTGX's next catalysts
Track Protagonist Therapeutics (PTGX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PTG-300 | Phase 2 | Polycythemia Vera | - | - |
Frequently asked questions
What is in Protagonist Therapeutics, Inc's drug pipeline?→
CatalystAlert tracks 1 drug candidate in Protagonist Therapeutics, Inc's (PTGX) pipeline across Phase 2. Its lead program is PTG-300 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Protagonist Therapeutics, Inc's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Protagonist Therapeutics, Inc (PTGX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PTGX biotech catalysts?→
Add PTGX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Protagonist Therapeutics, Inc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.